PsyIndex Weekly Update – May 31, 2021 – June 4, 2021

May 31, 2021 – June 4, 2021
The PsyIndex moved marginally higher last week as new companies continue to announce plans to go public. With the recent launch of the first U.S. ETF, investors also have much easier access to the market.

Market Performance

Weekly Performance: $122.08 (1.02%)

Powered by

CFN Enterprises Inc. (OTCQB: CNFN)

Top Gainers

Top Decliners

View All Index Constituents

Corporate News, Deals & Listings

  • Filament Health partnered with TrPR Psychedelic Research Program at UCSF to advance drug candidates through clinical trials. Press Release
  • BetterLife Pharma Inc. (CSE: BETR) appointed Henri Sant-Cassia of The Conscious Fund to its Board of Directors. Press Release
  • Optimi Health Corp. (CSE: OPTI) announced DTC eligibility and an uplisting to the OTCQB. Press Release
  • Silo Wellness Inc. (CSE: SILO) partnered to establish the first legal brick and mortar psychedelic and functional mushroom shop in the Western hemisphere. Press Release
  • The Good Shroom Co. (TSXV: MUSH) signed a contract with a top-tier Canadian retail distributor, Ecotrend. Press Release
Read More

Featured Content

Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.

Delic Holdings acquired all of the issued and outstanding shares in the capital of Complex Biotech Discovery Ventures Ltd., a federally-authorized psilocybin and cannabis research laboratory focused on extraction, analytical testing, and chemical process development.

Industry Developments

  • PharmaTher and TSRL have teamed up to develop microneedle patches to deliver psychedelics and antivirals. via Fierce Pharma
  • Nearly 40 percent of Americans approve the use of psychedelics for medical purposes. via KABC
  • The first psychedelics ETF comes to the U.S. as bills move forward in key states. via Benzinga

Primary Sponsor

Top Marijuana Blog